• BioLizard launches new AI-empowered “BioVerse” platform to facilitate data-driven R&D for global life sciences community

    Wednesday October 11th 2023

  • Agomab raises $100 million Series C to advance fibrosis-focused pipeline

    Wednesday October 11th 2023

  • SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform

    Monday October 9th 2023

  • Triple discovery unveils insights into type 2 diabetes

    Thursday September 28th 2023

  • SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

    Wednesday September 27th 2023

  • MDxHealth Signs Research Collaboration with University of Oxford

    Wednesday September 27th 2023

  • VIB and AB Biotek join forces to develop superior yeast strains for bioethanol production

    Tuesday September 26th 2023

  • New study discovers how neurons die in Alzheimer’s disease

    Friday September 15th 2023

  • Your news here?

  • Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development

    Tuesday September 12th 2023

  • SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV

    Friday September 8th 2023

  • SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure

    Friday September 1st 2023


Strategic Partners